Clinical significance of coagulation parameters in patients with pancreatic cancer
10.3760/cma.j.issn.1007-8118.2013.05.013
- VernacularTitle:凝血参数异常对胰腺癌诊治的临床意义
- Author:
Wei SUN
;
He REN
;
Peng JIN
;
Weidong MA
;
Wen XIN
;
Jihui HAO
- Publication Type:Journal Article
- Keywords:
Pancreatic neoplasms;
Blood coagulation disorders
- From:
Chinese Journal of Hepatobiliary Surgery
2013;(5):363-366
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the coagulation disorder status of patients with pancreatic cancer and to explore its role in tumor formation,progression and metastasis.Method The present study involved 114 patients with pancreatic cancer diagnosed by surgery or biopsy,and 40 healthy volunteers.For each individual,nine plasma coagulation parameters were tested using the STAGO Compact automated.Results The levels of plasma antithrombin Ⅲ (AT-Ⅲ) and protein C of the pancreatic cancer group were significantly reduced compared with the control group,while the levels of plasma PT,APTT,INR,FIB,F-Ⅷ,D-dimer (D-D) were significantly elevated.The level of plasma D-D increased with increase in clinical stage,while the level of AT-Ⅲ decreased.The level of plasma D-D became higher with worsening in histological grade.Conclusions Patients with pancreatic cancer were in a state of hypercoagulation,with reduced anticoagulation function and secondary hyperfibrinolysis.The level of Plasma D-D was significantly associated with the clinical stage,histological grade and distant metastasis.These together with AT-Ⅲ could be used as indicators to monitor patients with pancreatic cancer.
